HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leukotriene B(4) mediates sphingosylphosphorylcholine-induced itch-associated responses in mouse skin.

Abstract
In atopic dermatitis, the concentration in the skin of sphingosylphosphorylcholine (SPC), which is produced from sphingomyelin by sphingomyelin deacylase, is increased. In the present study, we investigated the itch-eliciting activity of SPC and related substances and the mechanisms of SPC action in mice. An intradermal injection of SPC, but not sphingomyelin and sphingosine, induced scratching, an itch-associated response, which was not suppressed by a deficiency in mast cells or the H(1) histamine receptor antagonist terfenadine. The action of SPC was inhibited by the mu-opioid receptor antagonist naltrexone. SPC action also was inhibited by the 5-lipoxygenase inhibitor zileuton and the leukotriene B(4) antagonist ONO-4057, but not by the cyclooxygenase inhibitor indomethacin. Moreover, SPC action was inhibited by the antiallergic agent azelastine, which suppresses the action and production of leukotriene B(4). Administration of SPC to the skin and to primary cultures of keratinocytes increased leukotriene B(4) production. SPC increased intracellular Ca(2+) ion concentration in primary cultures of dorsal root ganglion neurons and keratinocytes. These results suggest that SPC induces itching through a direct action on primary afferents and leukotriene B(4) production of keratinocytes. Sphingomyelin deacylase and SPC receptors may be previously unreported targets for antipruritic drugs.
AuthorsTsugunobu Andoh, Ayumi Saito, Yasushi Kuraishi
JournalThe Journal of investigative dermatology (J Invest Dermatol) Vol. 129 Issue 12 Pg. 2854-60 (Dec 2009) ISSN: 1523-1747 [Electronic] United States
PMID19657356 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Histamine H1 Antagonists, Non-Sedating
  • Narcotic Antagonists
  • Sphingomyelins
  • sphingosine phosphorylcholine
  • Phosphorylcholine
  • Leukotriene B4
  • Naltrexone
  • Terfenadine
  • Histamine
  • Sphingosine
  • Calcium
Topics
  • Animals
  • Calcium (metabolism)
  • Dermatitis, Atopic (chemically induced, immunology, metabolism)
  • Ganglia, Spinal (cytology, metabolism)
  • Histamine (metabolism)
  • Histamine H1 Antagonists, Non-Sedating (pharmacology)
  • Injections, Intradermal
  • Keratinocytes (metabolism)
  • Leukotriene B4 (immunology, metabolism)
  • Male
  • Mast Cells (immunology, metabolism)
  • Mice
  • Mice, Inbred ICR
  • Naltrexone (pharmacology)
  • Narcotic Antagonists (pharmacology)
  • Neurons (metabolism)
  • Phosphorylcholine (analogs & derivatives, immunology, pharmacology)
  • Pruritus (chemically induced, immunology, metabolism)
  • Skin (cytology, immunology, metabolism)
  • Sphingomyelins (immunology, pharmacology)
  • Sphingosine (analogs & derivatives, immunology, pharmacology)
  • Terfenadine (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: